menu
    • menu

    Company profile for UroGen Pharma

    NEW Drugs in Dev: 8
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    UroGen Pharma is a clinical-stage biopharmaceutical company developing advanced, minimally invasive treatments to address unmet needs in the field of urology, with a focus on uro-oncology. We have developed RTGel ™, a novel drug delivery technology platform, that is liquid when chilled, but gels at body temperature. We believe RTGel technology has the potential to be applied to a variety of unmet medical needs where increas...
    UroGen Pharma is a clinical-stage biopharmaceutical company developing advanced, minimally invasive treatments to address unmet needs in the field of urology, with a focus on uro-oncology. We have developed RTGel ™, a novel drug delivery technology platform, that is liquid when chilled, but gels at body temperature. We believe RTGel technology has the potential to be applied to a variety of unmet medical needs where increased exposure to the active drug would improve the therapeutic profile of existing drugs while decreasing toxicity associated with systemic delivery, making local therapy a potentially more effective treatment option.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    UroGen PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    499 Park Avenue, Suite 1200 New York, NY 10022
    Telephone
    Telephone
    46-768-9780
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.urogen.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/urogenpharma
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/urogenpharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Bio-Europe Spring

    Bio-Europe Spring

    Not Confirmed

    envelop Contact Supplier

    Bio-Europe Spring

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Journal of Urology Publishes ENVISION Trial Results for ZUSDURI
    Journal of Urology Publishes ENVISION Trial Results for ZUSDURI

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264559/0/en/Journal-of-Urology-Publishes-ENVISION-Trial-Results-Showing-72-2-24-Month-Duration-of-Response-with-ZUSDURI.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Urogen Applauds Bcan's Bladder Cancer Report On Recurrence Burden
    Urogen Applauds Bcan's Bladder Cancer Report On Recurrence Burden

    13 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/13/3255422/0/en/UroGen-Applauds-BCAN-s-New-Faces-of-Bladder-Cancer-Report-Highlighting-Recurrence-Burden-and-Fear-of-Recurrence.html

    GLOBENEWSWIRE
    13 Mar 2026
    Share Share
    UroGen Pharma Issues Inducement Grants Per Nasdaq LR 5635(C)(4)
    UroGen Pharma Issues Inducement Grants Per Nasdaq LR 5635(C)(4)

    06 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/06/3251317/0/en/UroGen-Pharma-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    06 Mar 2026
    Share Share
    UroGen Announces On-Track ZUSDURI Launch, 2025 Financials
    UroGen Announces On-Track ZUSDURI Launch, 2025 Financials

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247313/0/en/UroGen-Announces-ZUSDURI-Launch-is-On-Track-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    UroGen Renews Loan Deal With Pharmakon Advisors
    UroGen Renews Loan Deal With Pharmakon Advisors

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247288/0/en/UroGen-Announces-Refinanced-Term-Loan-Agreement-with-Pharmakon-Advisors.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    ZUSDURI Shows Durable CRs in Recurrent LG-IR NMIBC
    ZUSDURI Shows Durable CRs in Recurrent LG-IR NMIBC

    27 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/27/3246510/0/en/ZUSDURI-Achieves-Durable-Complete-Responses-Across-EORTC-Risk-Groups-in-Patients-with-Recurrent-LG-IR-NMIBC.html

    GLOBENEWSWIRE
    27 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search